IND Safety Reporting
Navigating FDA IND safety reporting requirements requires clarity across sponsors, investigators, research sites, and IRBs. WCG provides expert guidance and practical resources to help clinical research organizations understand IND safety reports, reporting responsibilities, IRB expectations, and evolving FDA guidance — all while supporting participant safety and efficient clinical trial oversight.
WCG Clinical | Insights
IND Safety Reporting: What Sites Need to Submit
Guide
WCG Clinical | Insights
How Should Sponsors, Investigators, and IRBs Navigate the FDA’s Updated IND Safety Reporting Guidance?
Blog Posts
WCG Clinical | Insights